Rowlands CF, Garrett A, Allen S, et al. The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification. Journal of medical genetics. 2024. doi:10.1136/jmg-2024-110034.
Wang Y, He Y, Shi Y, et al. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds. American journal of human genetics. 2024. doi:10.1016/j.ajhg.2024.04.002.
Funchain P, Ni Y, Heald B, et al. Germline Cancer Susceptibility in Individuals with Melanoma. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2023.11.070.
Fishbein JE, Dass LW, Lienczewski C, et al. Assessment of the Needs of Nephrology Divisions to Implement Return of Clinically Significant Research Genetic Results: A Survey of Nephrotic Syndrome Study Network (NEPTUNE) Investigators. Glomerular diseases. 2023;3(1):178-188. doi:10.1159/000533501.
Ye CJ, Chen J, Villani A-C, et al. Genetic analysis of isoform usage in the human anti-viral response reveals influenza-specific regulation of transcripts under balancing selection. Genome Res. 2018;28(12):1812-1825. doi:10.1101/gr.240390.118.
Kory N, Wyant GA, Prakash G, et al. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. Science. 2018;362(6416). doi:10.1126/science.aat9528.
Oza AM, DiStefano MT, Hemphill SE, et al. Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss. Hum Mutat. 2018;39(11):1593-1613. doi:10.1002/humu.23630.
Harrison SM, Dolinksy JS, Chen W, et al. Scaling resolution of variant classification differences in ClinVar between 41 clinical laboratories through an outlier approach. Hum Mutat. 2018;39(11):1641-1649. doi:10.1002/humu.23643.